Weekly Semaglutide vs. Liraglutide Efficacy Profile: A Network Meta-Analysis

Introduction: Glucagon-like peptide 1 receptor agonist (GLP-1 RA) is a class of hypoglycemic medications. Semaglutide once-weekly (QW) and liraglutide once-daily (OD) significantly improved glycemic control compared to placebo. To date, no long-term phase III trials directly comparing semaglutide an...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsugair, Hassan A., Alshugair, Ibrahim F., Alharbi, Turki J., Bin Rsheed, Abdulaziz M., Tourkmani, Ayla M., Al-Madani, Wedad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466858/
https://www.ncbi.nlm.nih.gov/pubmed/34574899
http://dx.doi.org/10.3390/healthcare9091125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466858/
https://www.ncbi.nlm.nih.gov/pubmed/34574899
http://dx.doi.org/10.3390/healthcare9091125

Ejemplares similares